Cramer tonight had a quick SELL BLOCK feature where he reviewed names he has previously liked and usually suggests taking your profits.
He has been behind Boston Scientific (BSX-NYSE) for some time thinking the negative cloud swirling was too much. He said buy at $16+ but now he said you can sell it now and need to sell it now. Cramer is hearing another stent rumor about problems that he thinks if are true will cause a real negative PR campaign against stents for some time, so he said take the 11% profit on his call and walk away.
Gilead (GILD-NASDAQ) is one he says is NOT on the SELL BLOCK after it rose 11% today and he thinks estimates are too low. He said you can sell a smal bit of it to be safe but hold most of it.
Laureate (LAUR-NASDAQ) is on he said by 14 months ago even though he hates the group. He thinks it is time to sell into the LBO/MBO now. He doesn’t want to be in the ARBITRAGE TRADE and it could have downside if the deal is not approved.
Cramer said 3M (MMM-NYSE) is PERMANENTLY on the SELL BLOCK. They are unpredictable and he said he made a mistake getting behind it. He’s throwing in the towel on it and management is in the way. He thinks this one is a bad DJIA stock that you can own better DJIA compoents; even if the next quarter is better it doesn’t mean the company is OK.
Smith & Wesson (SWHC-NASDAQ) is one where he is glad he maintained the sell stance.
Jon C. Ogg
February 1, 2007